September 24, 2026
Market insights predict the global cancer diagnostics industry will increase from USD 116.42 billion in 2025 to USD 211.85 billion by 2035, achieving a CAGR of 6.17%. The market is growing due to the rising global cancer incidence and increasing awar...
April 21, 2026
Based on market forecasts, the global next generation cancer diagnostics market, projected at USD 19.20 billion in 2025, is expected to reach USD 41.64 billion by 2035, growing at a CAGR of 8.05% over the forecast period. The market is driven by the ...
September 11, 2026
According to Payal Rabde, who specializes in disease diagnostics, healthcare services, and oncology research, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the AI in ...
September 04, 2026
According to Payal Rabde, who specializes in technologies and tests used to detect, identify, and monitor thyroid cancer, including imaging, biopsy, molecular testing, and laboratory-based diagnostics, with 4+ years of experience in market research a...
July 20, 2026
According to Payal Rabde, who specializes in periodontal tissue regeneration, bone grafting, alveolar bone regeneration, and guided bone regeneration, with 4+ years of experience in market research and industry analysis, extensive research indicates ...
June 03, 2026
U.S. Non-Invasive Cancer Diagnostics Market (By Product Type: Instruments, Reagents & Kits, Software & Services; By Therapeutic Area: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Liquid Biopsy, Imaging Technology, Microa...
April 21, 2026
Based on market forecasts, the global advanced liver cancer market, projected at USD 2.65 billion in 2024, is expected to reach USD 8.2 billion by 2034, growing at a CAGR of 11.94% over the forecast period. Emergence of diverse severe liver issues ...
February 24, 2026
According to market projections, the global cancer biopsy market, valued at USD 36.61 billion in 2025, is anticipated to reach USD 205.72 billion by 2035, growing at a CAGR of 18.84% over the next decade. Increasing advancements in biopsy technolog...
August 12, 2026
According to Payal Rabde, who specializes in medicines that prevent, reduce, and manage side effects of cancer and its treatments, helping improve patient comfort, treatment adherence, and overall quality of life, with 4+ years of experience in marke...
April 21, 2026
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing ...
April 21, 2026
According to market projections, the radiation oncology sector is expected to grow from USD 12.45 billion in 2025 to USD 36.78 billion by 2035, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the glob...
April 21, 2026
Cervical cancer is caused by HPV infections and diagnosed through tests like Pap tests, HPV tests, biopsies, and imaging. Regular screenings and advancements in diagnostic techniques are driving market growth. Initiatives like the WHO’s Global ...
April 21, 2026
Based on market forecasts, the bladder cancer vaccines market was valued at USD 370.2 million in 2025 and is expected to grow from USD 456.83 million in 2026 to approximately USD 3,031.01 million by 2035, registering a strong CAGR of 23.4% during 202...
August 21, 2026
According to our market projections, the brain cancer sector is expected to grow from USD 3.4 billion in 2026 to USD 8.06 billion by 2035, reflecting a CAGR of 10.07%. Brain Cancer Market (By Product/Solution Type: Therapeutic Treatments, Diagnostic ...
October 07, 2026
The report analyses the India home-based cancer care market based on market overview, market size & growth, market segmentation, demand landscape, competitive landscape, key ecosystem players, value chain analysis, customer analysis, market drive...
July 16, 2026
According to our projections, the global lung cancer trial market, valued at USD 4.34 billion in 2025, is anticipated to reach USD 9.76 billion by 2035, growing at a CAGR of 8.45% over the next decade. The lung cancer trial market is growing due to i...
April 21, 2026
According to market projections, the cancer stem cells sector is expected to grow from USD 3.2 billion in 2024 to USD 8.04 billion by 2034, reflecting a CAGR of 9.64%. Stem cell-based therapies are highly useful in providing high-quality treatment, d...
October 13, 2026
According to Payal Rabde, who specializes in diagnosis and management, nutritional support and metabolic therapies, pharmacological treatments, and supportive and palliative care, digital pathology image analysis, AI-powered cancer diagnosis, and bio...
April 21, 2026
According to market projections, the NUT midline carcinoma treatment sector is expected to grow from USD 23.92 billion in 2025 to USD 68.89 billion by 2035, reflecting a CAGR of 11.15%. The growth of the market is driven by innovations in targeted th...
August 31, 2026
According to Payal Rabde, who specializes in the identification of unique molecular traits, genetic changes in cancer patients, and biological signals to detect, diagnose, and guide the patient for the treatment of cancer, with 4+ years of experience...
October 15, 2026
According to Payal Rabde, who specializes in targeted therapies, HER2-targeted therapies, and precision oncology, biomarker-based diagnostics, with 4+ years of experience in market research and industry analysis, extensive research indicates strong g...
April 21, 2026
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
July 31, 2026
Market insights predict the global pancreatic cancer industry will increase from USD 3.42 billion in 2026 to USD 10.87 billion by 2035, achieving a CAGR of 13.7%. Pancreatic cancer is a deadly disease that starts in the pancreas, an organ that helps ...
April 21, 2026
According to market projections, the global cancer biologics market, valued at USD 110.91 billion in 2024, is anticipated to reach USD 232.02 billion by 2034, growing at a CAGR of 7.66% over the next decade. Rising cancer research is anticipated...
April 27, 2026
U.S. Bispecific Antibody Market (By Therapeutic Area/Indication: Oncology, Immuno-inflammation/Autoimmunity, Infectious Diseases, Ophthalmology/Rare Diseases/Others; By Format/Architecture: Dual-variable/IgG-based bispecifics, T-cell Engagers, Bispec...
April 21, 2026
Market insights predict the global cervical cancer treatment industry will increase from USD 8.65 billion in 2024 to USD 14.68 billion by 2034, achieving a CAGR of 5.44%. In 2024, North America led the cervical cancer treatment market, with Europe se...
January 20, 2026
Projections indicate the global chemotherapy market will increase from USD 10.29 billion in 2025 to USD 21.33 billion by 2035, experiencing a CAGR of 7.56% over the next 10 years. In 2024, North America led the global chemotherapy market with a 45% s...
September 15, 2026
According to Payal Rabde, who specializes in pharmaceuticals, clinical trials, healthcare services, and biotechnology, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in t...
August 12, 2026
The market is growing due to its ability to accelerate drug discovery and optimize personalized treatment strategies. This leads to faster development timelines, reduced costs, and improved patient outcomes....
April 24, 2026
CAR T-Cell Neurotoxicity Detection Market (By Detection Method: Biomarker-based Detection, AI-based & Wearable Monitoring Neuroimaging, Electrophysiology, Cognitive & Behavioral Assessment Tools; By Product/Service Type: Diagnostic Kits &...
April 21, 2026
According to forecasts, the Japan cell cancer vaccine market will grow from USD 320.6 million in 2024 to USD 576.4 million by 2034, with an expected CAGR of 6.04%. The Japan cell cancer vaccine market is expanding due to rising incidences of cancer a...
April 21, 2026
According to market projections, the cancer vaccines sector is expected to grow from USD 11.38 billion in 2024 to USD 33.61 billion by 2034, reflecting a CAGR of 11.44%. The increasing prevalence of cancer, research and development and continuous eff...
February 11, 2026
Based on our market forecasts, the metastatic pancreatic cancer treatment market was valued at USD 3.68 billion in 2025 and is projected to grow from USD 3.91 billion in 2026 to approximately USD 6.75 billion by 2035, registering a CAGR of 6.25% duri...
October 01, 2026
The global breast cancer liquid biopsy market size was estimated at USD 229.6 million in 2025 and is predicted to increase from USD 263.58 million in 2026 to approximately USD 912.83 million by 2035, expanding at a CAGR of 14.8% from 2026 to 2035. Ou...
October 15, 2026
The report analyses the personalized cancer vaccine market based on market key takeaways, market overview, market trends & future outlook, segmental insights, regional insights, top vendors, and recent developments. The analysis was led by Payal ...
October 12, 2026
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for p...
February 24, 2026
Based on our market forecasts, the pancreatic cancer precision medicine sector will expand from USD 815.63 million in 2025 to USD 4739.26 million by 2035, experiencing a CAGR of 19.24%....
April 21, 2026
Projections indicate that, U.S. cell therapy industry is projected to rise from USD 6.62 billion in 2024 to USD 46.26 billion by 2034, reflecting a CAGR of 21.46% over the next decade. The increasing prevalence of chronic conditions is driving the gr...
October 12, 2026
According to Payal Rabde, who specializes in targeted therapies for head and neck cancers, immunotherapy treatments, including immune checkpoint inhibitors, and chemotherapy drugs and combination therapies, with 4+ years of experience in market resea...
January 16, 2026
According to market projections, the global hyperthermia cancer treatment market, valued at USD 210.54 million in 2025, is anticipated to reach USD 380.63 million by 2035, growing at a CAGR of 6.1% over the next decade. The rising incidences of cance...
March 25, 2026
U.S. CAR T-Cell Therapies Market (By Drug Type: Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Others; By Indication: Lymphoma, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Others; By E...
April 21, 2026
Based on market forecasts, the global whole genome sequencing market, projected at USD 2.15 billion in 2024, is expected to reach USD 15.96 billion by 2034, growing at a CAGR of 22.2% over the forecast period. The market is growing due to increasing ...
September 29, 2026
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 24.24 billion in 2025 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding ...
April 21, 2026
Based on market forecasts, the circulating tumor cells sector will expand from USD 13.06 billion in 2024 to USD 46.9 billion by 2034, experiencing a CAGR of 13.64%. The growing prevalence of cancer drives the market’s growth....
April 21, 2026
Expansion of healthcare facilities, especially in emerging economies, is improving access to advanced cancer treatments, further supporting market expansion. North America has a robust healthcare system with significant spending on advanced treatme...
April 21, 2026
Market insights predict, the breast cancer screening tests industry is expected to grow from USD 4.44 billion in 2024 to USD 8.77 billion by 2034, driven by a CAGR of 7.04%. The breast cancer screening tests market is growing due to its major applica...
August 21, 2026
According to Payal Rabde, who specializes in silicone and saline implants used for breast augmentation and reconstruction, and products available in various shapes, sizes, profiles, and surface designs, with 4+ years of experience in market research ...
April 21, 2026
According to market projections, the CDK4/6 inhibitors sector is expected to grow from USD 11.38 billion in 2024 to USD 46.96 billion by 2034, reflecting a CAGR of 15.34%. The rising prevalence of cancer and growing research and development activit...
April 21, 2026
According to market projections, the blood product sector is expected to grow from USD 39.96 billion in 2025 to USD 62.65 billion by 2035, reflecting a CAGR of 4.6%, driven by rising demand in surgeries, cancer care, and trauma cases. North America l...
October 15, 2026
The ESR1-targeted breast cancer therapy market is projected to reach around US$ 4.17 billion by 2035, expanding at a CAGR of 21.8% between 2026 and 2036. The ESR1-targeted breast cancer therapy market report examines market size, segmentation, compet...
October 05, 2026
The report analyses the APAC multi-cancer early detection market based on market key takeaways, market overview, segmental insight, regional insights, TAM, SAM, SOM, consumer behavior & buyer intelligence analysis, and strategic key takeaways. Th...
October 09, 2026
The Brazil rare disease diagnostics market size was USD 40.6 mn in 2025 and is likely to grow at 13.4% CAGR by 2035. The report analyses the Brazil rare disease diagnostics market based on market overview, market size & growth, market...
April 21, 2026
Based on market forecasts, the multiplex PCR kit sector will expand from USD 1.25 billion in 2024 to USD 3.43 billion by 2034, experiencing a CAGR of 10.64%. The Multiplex PCR Kit Market is growing due to its significant applications in diagnosing in...
January 02, 2026
Market insights predict, the U.S. Tuberculosis (TB) Diagnostics Market was valued at USD 650.8 million in 2025 and is projected to reach USD 687.51 million in 2026, further expanding to USD 1,126.5 million by 2035 at a CAGR of 5.64% (2026–...
April 21, 2026
According to market projections, the global ultra-high-end CT scanners market, valued at USD 5.89 billion in 2024, is anticipated to reach USD 10.69 billion by 2034, growing at a CAGR of 6.16% over the next decade. The ultra-high-end CT scanners mark...
March 11, 2026
Market insights predict, the North America in-vitro diagnostics industry is expected to grow from USD 54.09 billion in 2025 to USD 90.05 billion by 2035, driven by a CAGR of 5.23%. In 2024, reagents led North America's in-vitro diagnostics market. Se...
April 21, 2026
Based on market forecasts, the U.S. oncology molecular diagnostics sector will expand from USD 810 million in 2024 to USD 2570.17 million by 2034, experiencing a CAGR of 12.24%. In 2024, breast cancer dominated the market, while liver cancer is expec...
August 10, 2026
According to Payal Rabde, who specializes in in vitro diagnostics, clinical diagnostics, and healthcare market intelligence, with 4+ years of experience in market research and industry analysis. Her research indicates that the global in vitro diagnos...
August 12, 2026
DNA diagnostics involve testing genes or chromosomes to detect genetic conditions or predict disease risks. It's used in healthcare, research, biotechnology, and forensics for purposes like newborn screening, genetic counseling, and personalized trea...
April 21, 2026
Core clinical molecular diagnostics applies molecular biology techniques to study diseases like cancer and infections, focusing on patient care. With the aging population increasing chronic disorders, the demand for biomarker analysis grows. Advancem...
October 15, 2026
The report analyses the livestock diagnostics market based on market key takeaways, market overview, market trends & future outlook, segmental insights, regional insights, top vendors, and recent developments. The analysis was led by Payal Rabde,...
September 21, 2026
According to Payal Rabde, who specializes in medical imaging, disease detection, diagnostic decision support, predictive analytics, and automated analysis of clinical, with 4+ years of experience in market research and industry analysis, extensive re...
June 16, 2026
According to Shivani Zoting, who specializes in respiratory infectious diseases, diagnostic devices, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, extensive research indicates strong g...
September 03, 2026
Projections indicate that, molecular diagnostics industry is projected to rise from USD 17.1 billion in 2025 to USD 28.66 billion by 2035, reflecting a CAGR of 5.3% over the next decade. The molecular diagnostics is growing rapidly, driven by advance...
October 13, 2026
According to Payal Rabde, who specializes in molecular diagnostics, immunodiagnostics, hematology diagnostics, and in-vitro diagnostic testing, with 4+ years of experience in market research and industry analysis, extensive research indicates strong ...
September 03, 2026
According to Payal Rabde, who specializes in detecting and confirming malaria infections using rapid diagnostic tests, microscopy, molecular test, and other diagnostic technologies, with 4+ years of experience in market research and industry analysis...
August 18, 2026
According to Payal Rabde, who specializes in diagnostic tests, reagents, and technologies used to detect, monitor, and diagnose diseases from biological samples, with 4+ years of experience in market research and industry analysis, extensive research...
October 09, 2026
According to Payal Rabde, who specializes in identifying and measuring allergic conditions through diagnostic test, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities i...
July 15, 2026
Market insights predict the Europe in-vitro diagnostics industry will increase from USD 30.86 billion in 2026 to USD 51.82 billion by 2035, achieving a CAGR of 5.93%. Rising cases of oncology and chronic conditions are driving the Europe in-vitro dia...
October 13, 2026
According to Payal Rabde, who specializes in AI-powered solutions, machine learning, deep learning, computer vision, and predictive analytics, and improving diagnostic accuracy, reducing turnaround time, and enabling perosnalized animal healthcare, w...
October 05, 2026
According to Payal Rabde, who specializes in detect metallic contamination in pharmaceutical products, ensuring product quality and patient safety, and ensuring product and patient safety, with 5+ years of experience in market research and industry...
April 21, 2026
The global LC-MS/MS-based diagnostics market is growing because of the rising demand for diagnostic services. North America is leading the market due to the region’s focus on developing highly advanced healthcare infrastructure....
August 27, 2026
According to Payal Rabde, who specializes in healthcare diagnostics and life sciences market research, with 4+ years of experience in market research and industry analysis. My research indicates that the oncology molecular diagnostics market will exp...
May 18, 2026
Oncology Companion Diagnostic Market (By Product & Services: Product, Software; By Technology: Polymerase Chain Reaction, Next-generation Sequencing, Immunohistochemistry, In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization, Other Tech...
August 04, 2026
Based on market forecasts, the stroke diagnostics and therapeutics sector will expand from USD 43.71 billion in 2026 to USD 81.71 billion by 2035, experiencing a CAGR of 7.2%. Stroke diagnostics and therapeutics focus on quickly identifying and treat...
February 18, 2026
According to our projections, the digital diagnostics system market was valued at USD 1.45 billion in 2025 and reached USD 1.71 billion in 2026, and it is projected to grow to USD 7.67 billion by 2035, expanding at a CAGR of 18.12% during 2026–...
September 15, 2026
Projections indicate that, the global allergy diagnostics and therapeutics market will increase from USD 36.55 billion in 2025 to USD 84.59 billion by 2035, experiencing a CAGR of 8.76% over the next 10 years. The market is growing due to the rising ...
August 25, 2026
According to Payal Rabde, who specializes in personalized diagnosis, biomarker testing, genomic analysis, targeted therapies, and patient-specific treatment decisions, with 4+ years of experience in market research and industry analysis, extensive re...
October 15, 2026
According to Payal Rabde, who specializes in the diagnosis of infectious and non-infectious diseases, clinical pathology testing, and molecular diagnostics, with 4+ years of experience in market research and industry analysis, extensive research indi...
August 27, 2026
According to Payal Rabde, who specializes in diagnostic imaging, real-time visualization, parental care, cardiovascular assessment, disease detection, and image-guided medical procedures, with 4+ years of experience in market research and industry an...
September 08, 2026
Market insights predict, the veterinary infectious disease diagnostics industry is expected to grow from USD 3.12 billion in 2026 to USD 6.21 billion by 2035, driven by a CAGR of 7.95%.The growing infectious disease cases and awareness about animal h...
September 30, 2026
The global autoimmune disease diagnostics market size was estimated at USD 6.11 billion in 2025 and is predicted to increase from USD 6.49 billion in 2026 to approximately USD 10.5 billion by 2035, expanding at a CAGR of 6.22% from 2026 to 2035. Our ...
April 21, 2026
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
April 21, 2026
According to market projections, the global ultrasound market, valued at USD 10.1 billion in 2024, is anticipated to reach USD 20.34 billion by 2034, growing at a CAGR of 7.26% over the next decade. Rising demand for non-invasive, cost-effective diag...
September 09, 2026
According to Payal Rabde, who specializes in the therapeutic area, mental health solutions, and disease diagnostics, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the...
April 21, 2026
Market insights predict, the infectious disease diagnostics industry is expected to grow from USD 25.01 billion in 2024 to USD 62.95 billion by 2034, driven by a CAGR of 9.67%.The market is growing due to healthcare providers seeking faster, more rel...
April 21, 2026
Projections indicate that, the global nuclear medicine software market will increase from USD 895.04 million in 2024 to USD 2109.19 million by 2034, experiencing a CAGR of 8.95% over the next 10 years.The global market is fueled by continuous colla...
September 29, 2026
The report analyses the Middle East oncology diagnostics market based on market key takeaways, market overview, segmental insight, TAM, SAM, SOM, consumer behavior & buyer intelligence analysis, company analysis, and strategic key takeaways. ...
August 19, 2026
According to Payal Rabde, who specializes in detecting diseases and biomarkers using antibodies, antigens, and immune-based diagnostic techniques, with 4+ years of experience in market research and industry analysis, extensive research indicates stro...
April 21, 2026
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susce...
September 09, 2026
According to our forecast, the neurodiagnostics market is expected to grow from USD 20.68 billion in 2026 to USD 43.27 billion by 2035, driven by the rising prevalence of neurological disorders and the expanding use of AI-powered diagnostic technolog...
+1 9197 992 333
+91 93077 85324
